Related Experiment Videos
Botulinum toxin A for spasticity, muscle spasms, and rigidity
M A Grazko1, K B Polo, B Jabbari
1Neurology Service, Walter Reed Army Medical Center, Washington, DC. 20307-5001, USA.
Neurology
|April 1, 1995
Summary
Botulinum toxin A effectively treats spasticity and rigidity, improving patient function and reducing pain. This double-blind study confirmed its benefits for disabling neurological conditions.
Area of Science:
- Neurology
- Pharmacology
Background:
- Spasticity and rigidity are debilitating conditions affecting muscle tone and movement.
- Botulinum toxin A is a neurotoxin with potential therapeutic applications.
Purpose of the Study:
- To evaluate the efficacy of botulinum toxin A in patients with spasticity and rigidity.
- To assess the impact of botulinum toxin A on muscle tone, functionality, and pain.
Main Methods:
- A double-blind, placebo-controlled crossover trial involving 12 patients with spasticity and 8 with rigidity.
- Assessment of muscle tone using the Ashworth Scale and Unified Parkinson's Disease Rating Scale.
- Evaluation of functionality, nursing care, and pain before and after treatment.
Main Results:
- Botulinum toxin A significantly reduced muscle tone in all spasticity patients and 7/8 rigidity patients.
- Improved functionality was observed in 8/12 spasticity patients and 4/7 rigidity patients.
- Painful spasms decreased in 5/5 spasticity patients, and joint/muscle pain reduced in 4/5 rigidity patients.
Conclusions:
- Botulinum toxin A is an effective treatment for the disabling effects of spasticity and rigidity.
- The treatment demonstrated a favorable safety profile and was well-tolerated by patients.